ALKEM logo

Alkem Laboratories Stock Price

Symbol: NSEI:ALKEMMarket Cap: ₹588.4bCategory: Pharmaceuticals & Biotech

ALKEM Share Price Performance

₹4,921.00
-402.10 (-7.55%)
24.6% undervalued intrinsic discount
₹6,528.02
Fair Value
₹4,921.00
-402.10 (-7.55%)
24.6% undervalued intrinsic discount
₹6,528.02
Fair Value
Price ₹4,921.00
AnalystHighTarget ₹6,528.02
AnalystConsensusTarget ₹5,171.33
AnalystLowTarget ₹4,030.00

ALKEM Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value ₹6.53k 24.6% undervalued intrinsic discount

Rising Global Healthcare Demand And US CDMO Will Boost Generic Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value ₹5.17k 4.8% undervalued intrinsic discount

Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value ₹4.03k 22.1% overvalued intrinsic discount

Rising Cost Pressures And Regulatory Risks Will Undercut Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

ALKEM Community Fair Values

Recent ALKEM News & Updates

No updates

Alkem Laboratories Limited Key Details

₹129.6b

Revenue

₹49.3b

Cost of Revenue

₹80.4b

Gross Profit

₹58.7b

Other Expenses

₹21.7b

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 12, 2025
Earnings per share (EPS)
181.11
Gross Margin
62.01%
Net Profit Margin
16.70%
Debt/Equity Ratio
8.5%

Alkem Laboratories Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ALKEM

Founded
1973
Employees
18785
CEO
Vikas Gupta
WebsiteView website
www.alkemlabs.com

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Indian Market Performance

  • 7 Days: 0.2%
  • 3 Months: 5.2%
  • 1 Year: -2.4%
  • Year to Date: -1.1%
The market has been flat over the last week. In line with that, the market has also been flat over the past year. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading